ME2 pathology managed service for Northampton goes to Roche Diagnostics
- Northampton General Hospital NHS Trust
- East Midlands
- Call-off from a framework agreement, 1 bid
- 4 June 2026 to 3 June 2036
Northampton General Hospital NHS Trust has hired Roche Diagnostics to run its pathology managed service.
The service comes in two phases. Phase 1 covers biochemistry and haematology alongside general managed services, with the equipment and IT to match. In phase 2 the supplier manages subcontractors for microbiology, cellular pathology, immunology and blood transfusion. The supplier also has to draw up requirements and test the market.
The Midlands and East 2 (ME2) Network, a pathology partnership of NHS trusts, ran the competition. It used lot 1 of NHS Supply Chain's Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service framework. The firm made the only bid. The trust awarded its own £14m contract to the firm in June 2026, and it runs to June 2036.
Contract ends June 2036
- What
- Pathology managed services and blood sciences analysers
- Supplier
- Roche Diagnostics
- Value
- £14m
- How it was bought
- Call-off from a framework agreement
- 1 bid
- Dates and next
- Jun 2026 to Jun 2036